Amgen stock gains on Novo Nordisk's weightloss drug blunder

4 weeks ago 8
ARTICLE AD BOX
Amgen stock gained more than 2% in Friday’s morning session after foreign weightloss drug competitor NovoNordisk (NVO) plunged following the results of new drug testing.
Read Entire Article
  1. Homepage
  2. Forex and Gold
  3. Amgen stock gains on Novo Nordisk's weightloss drug blunder

Related

Sensex, Nifty Edge Higher In Cautious Trade

Sensex, Nifty Edge Higher In Cautious Trade

3 weeks ago 22
Philippines' Budget Balance Plunges to -213.0B in November 2024

Philippines' Budget Balance Plunges to -213.0B in November 2...

3 weeks ago 16
Japan's November Construction Orders Plummet by 10.2% Year-Over-Year

Japan's November Construction Orders Plummet by 10.2% Year-O...

3 weeks ago 19
RIGHT SIDEBAR TOP AD

Trending

1. Aman Jaiswal
2. Rinku Singh Engagement
3. Auto Expo 2025
4. Coldplay
5. Bharat Mobility Global Expo 2025
6. Azaad
7. Axis Bank share price
8. Sakat Chauth Vrat Katha
9. Pakistan vs West Indies
10. Manchester United
RIGHT SIDEBAR BOTTOM AD
English (US) English (US)
About Us · Contact Us · Terms & Conditions ·

© News125.com - News aggregator & Search Engine 2025. All rights are reserved